Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...
Biotechnology company Bracco Imaging announced its expansion into the cell-therapy manufacturing space, establishing a new ...
Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...
Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Cell therapy, one of the most promising frontiers in modern medicine, holds the potential to cure once-incurable diseases such as cancer and genetic disorders. But for all its promise, manufacturing ...
Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...
Bracco Imaging is expanding into the cell therapy space to explore new applications of its long-established microbubble technology.
The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...
- Joint venture will aim to develop a cell therapy manufacturing platform through robotics and will offer access to startups and academic institutions - In the pharmaceutical industry, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results